본문

  1. Home
13 Results:AA:J Y REGINSTER 0.390 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
1
Managing the osteoporotic patient today
Managing the osteoporotic patient today
Reginster, J. Y, | Elsevier Inc | 2007 ,
2
Adherence and persistence: Impact on outcomes and health care resources
Adherence and persistence: Impact on outcomes and health care resources
Reginster, J. Y, | Elsevier Inc | 2006 ,
3
Osteoporosis: A still increasing prevalence
Osteoporosis: A still increasing prevalence
Reginster, J. Y., | Elsevier Inc | 2006 ,
4
Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women
Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women
Alexandersen, P., | Elsevier Inc | 2007 ,
5
The role of calcium and vitamin D in the management of osteoporosis
The role of calcium and vitamin D in the management of osteoporosis
Rizzoli, R., | Elsevier Inc | 2008 ,
6
Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age
Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age
Seeman, E., | Elsevier Inc | 2010 ,
7
Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women
Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women
Hiligsmann, M. l., | Elsevier Inc | 2008 ,
8
Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women
Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women
Hiligsmann, M., | Elsevier Inc | 2010 ,
9
Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women
Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women
Hiligsmann, M., | Elsevier Inc | 2010 ,
10
Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years
Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years
Reginster, J. Y., | Elsevier Inc | 2009 ,
처음12이후마지막